Trial Profile
A Phase 1 Study to determine the effect of a high fat meal on the pharmacokinetics of Brivanib in Healthy Subjects.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 16 Jul 2019
Price :
$35
*
At a glance
- Drugs Brivanib alaninate (Primary)
- Indications Solid tumours
- Focus Pharmacokinetics
- Sponsors Bristol-Myers Squibb
- 28 Dec 2011 Status changed from not yet recruiting to completed as reported by Australian New Zealand Clinical Trials Registry.
- 27 Apr 2011 New trial record